March 17 (Reuters) - Sequana Medical NV SEQUA.BR :
* SEQUANA MEDICAL ANNOUNCES 2020 FULL YEAR RESULTS AND 2021
OUTLOOK
* FY REVENUE EUR 963,000, DOWN -1%
* FY NET LOSS EUR 19.1 MILLION VERSUS EUR 15 MILLION
* SUCCESSFUL EQUITY PLACEMENTS EXTEND CASH RUNWAY INTO Q2
2022
* FY BASIC LOSS PER SHARE EUR 1.25
* DEPENDING ON FURTHER COVID-19 DEVELOPMENTS, NORMAL
COMMERCIAL
ACTIVITY IN EUROPE IS EXPECTED TO RESUME IN H2 2021
* EUROPEAN ALFAPUMP SALES EXPECTED TO BE LIMITED IN H1 2021
* NORMAL COMMERCIAL ACTIVITY IN EUROPE IS EXPECTED TO RESUME
IN H2
2021 FOR ALFAPUMP
Source text for Eikon: ID:nGNX6b3pS4
Further company coverage: SEQUA.BR
((Reuters.Briefs@thomsonreuters.com;))